Consistently, pancreatic cancer cells without expressing mutated K-ras or human lung epithelial BEAS-2B cells were non-responsive to GO6976 as well as to the combination treatment of GO6976 plus NAC. This evidence concerns the gene KRAS and familial pancreatic carcinoma.